v3 Template
C

CytoReason

Biotechnology and Healthcare ~400 employees
Founded
--
Employees (Est.)
~400
20 leaders known
Total Funding
$80.0M
Funding Rounds
1
Last Funding
2024-07-17

About CytoReason

CytoReason is a company focused on transforming medicine from trial and error to predictable outcomes through advanced disease modeling. Their mission is to bring data to life by providing comprehensive models of human diseases to aid in drug development and portfolio management.

Products & Services

CytoReason Disease Model:A comprehensive model of human diseases that maps disease and drug mechanisms by modeling and comparing treatments and patient groups.
Drug Portfolio Management:A platform to prioritize drug programs, compare treatments to competitors, and analyze drugs across patient populations.
Data-Driven Decision Platform:A unified platform offering deep drug profiles for scientists and a bird's-eye view of portfolios for executives, with live data updates for accurate predictions and risk assessment.

Specialties

AI Disease Modeling Drug Development Portfolio Management Inflammatory Bowel Disease (IBD) Research

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Equity Investment
T: -
FT: Equity Investment 		A: 80000000
MR: -
FA: $80M
FAN: 80000000 		D: 2024-07-17
FD: 2024-07-17 		4 investors
Equity Investment Latest
2024-07-17
$80.0M
4 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

D

David Harel

Co-Founder & CEO

LinkedIn (Pro only)
P

Prof. Shai Shen-Orr

Co-Founder & Chief Scientist

LinkedIn (Pro only)
P

Prof. Yehuda Chowers, MD

Chief Medical Officer

LinkedIn (Pro only)
A

Adir Katz

Chief Data Scientist

E

Elad Peleg

CFO and COO

N

Nicole van Poppel, PhD

Chief Business Officer

View 17 more team members with Pro

Unlock Full Team Directory

Recent News

CytoReason Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology and Healthcare
Company Size
~400 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro